wve-210201
Nucleic acidexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
1
Phase 4
0
Earliest trial started Jan 24, 2018 (NCT03508947)
Timeline
Indications
Mechanism of action
- DystrophinSupplementation
DMD supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03907072 | Phase 2/Phase 3 (Phase 3) | Jul 31, 2019 | Wave Life Sciences |
| NCT03508947 | Phase 1 | Jan 24, 2018 | Wave Life Sciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Wave Life Sciences | For profit | 2 | 2 | 2 | 2018 |
1 organizations
Page 1 / 1